olmesartan medoxomil has been researched along with Cardio-Renal Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, K; Homma, T; Ikeda, M; Manabe, K; Mizuno, M; Sada, T; Sonoda, H | 1 |
1 other study(ies) available for olmesartan medoxomil and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardio-Renal Syndrome; Gene Expression; Imidazoles; Kidney; Male; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Nephrectomy; Olmesartan Medoxomil; Proteinuria; Rats; Receptor, Angiotensin, Type 1; Renin; Spironolactone; Tetrazoles | 2012 |